QLGN (Qualigen Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on QLGN (Qualigen Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

QLGN

Qualigen Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
Oct 23, 2025
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?
Oct 13, 2025
Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)
Sep 30, 2025
This Penny Stock Is Surging Big Time on a Tie-Up With Faraday Future and a Push Into Crypto. Should You Buy Its Shares Here?
Sep 23, 2025
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
Jul 28, 2025
Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock
Jul 28, 2025
Qualigen Granted New Patents Covering 25 Countries
Jul 16, 2025
Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
May 19, 2025
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
May 1, 2025
Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme
Apr 1, 2025
Qualigen to participate in next funding round for NanoSynex
Jan 28, 2025
Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
Dec 5, 2024
Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
Nov 25, 2024
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
Nov 19, 2024

Reviews